2026 Development and validation of venous thromboembolism-bidirectional encoder representations from transformers (VTE-BERT) natural language processing model. Omid Jafari, Shengling Ma, Barbara D. Lam, Jun Y. Jiang, Emily Zhou, Mrinal Ranjan, Justine Ryu, Raka Bandyo, Arash Maghsoudi, Bo Peng, Christopher I. Amos, Abiodun Oluyomi, Nathanael R. Fillmore, Jennifer La‡, Ang Li‡‡ Equal senior authorship Journal of Thrombosis and Haemostasis24(7), 2522-2531 Natural Language Processing External Validation Clinical Notes Radiology and Pathology Reports Cancer Patients
2025 Validation of a Risk Score for Cancer-Associated Thrombosis Using Nationwide EHR Data. Ang Li, Omid Jafari, Barbara D. Lam, Jun Y. Jiang, Rock Bum Kim, Shengling Ma, Emily Zhou, Joyce W. Tiong, Elizabeth C. Chiang, Justine Ryu, Christopher I. Amos, Jennifer La, Nathanael R. Fillmore JAMA Network Open8(11), e2544428 Cancer-Associated Thrombosis Electronic Health Records External Validation Model Validation Predictive Modeling
2024 Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study. Shengling Ma†, Jennifer La†, Kaitlin N. Swinnerton, Danielle Guffey, Raka Bandyo, Las Pozas Giordana De, Katy Hanzelka, Xiangjun Xiao, Cristhiam M. Rojas-Hernandez, Christopher I. Amos, Vipul Chitalia, Katya Ravid, Kelly W. Merriman, Christopher R. Flowers, Nathanael Fillmore‡, Ang Li‡† Equal first authorship · ‡ Equal senior authorship American Journal of Hematology99(7), 1230-1239 U.S. Veterans and VA Data Retrospective Cohort Study Cancer-Associated Thrombosis Lymphoma Predictive Modeling
2023 Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy. Ang Li, Sarah B. May, Jennifer La, Kylee L. Martens, Christopher I. Amos, Christopher R. Flowers, Nhan V. Do, Mary T. Brophy, Vipul Chitalia, Katya Ravid, John Michael Gaziano, Nathanael R. Fillmore American Journal of Hematology98(8), 1214-1222 U.S. Veterans and VA Data Retrospective Cohort Study Cancer-Associated Thrombosis Immune Checkpoint Inhibitors Risk Factors
2023 Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems. Ang Li†, Jennifer La†, Sarah B. May, Danielle Guffey, Costa Wilson L. da, Christopher I. Amos, Raka Bandyo, Emily M. Milner, Karen M. Kurian, Daniel C. R. Chen, Nhan V. Do, Carolina Granada, Nimrah Riaz, Mary T. Brophy, Vipul Chitalia, J. Michael Gaziano, David A. Garcia, Marc Carrier, Christopher R. Flowers, Neil A. Zakai‡, Nathanael R. Fillmore‡† Equal first authorship · ‡ Equal senior authorship Journal of Clinical Oncology41(16), 2926-2938 Cancer-Associated Thrombosis Predictive Modeling Retrospective Cohort Study External Validation U.S. Veterans and VA Data
